RESEARCH TRIANGLE PARK – Trio Labs has raised $3,820,669 in equity from 36 investors, according to an SEC filing.
The company, based in Research Triangle Park, fabricates precision metal parts through its proprietary processes that allow manufacturers to scale quickly and effectively from rapid prototyping to full production, and uses a patent-pending technology, Resin Infused Powder Lithography (RIPL).
The aim is to deploy their technology to change how medical devices are manufactured, delivering a next generation of devices to the marketplace that will increase patient care and improve patient outcomes.
“Additive Manufacturing has long been a favorite of design engineers for its ability to produce complex geometries,” reads the company’s website. “RIPL brings this design flexibility to a production level, allowing for previously impossible devices to be made in high volume.”
According to the company, its technology is compatible with any alloy or other ceramic that’s used in powder injection molding.
The proceeds of the sale will be used for working capital, according to the filing, which the company notes may include compensation to executive officers. The money raised is part of a total offering amount of up to $5 million. The company did not respond to WRAL TechWire’s request for comment. The company was formerly based in the First Flight Venture Center and was a recipient of an NC IDEA SEED grant recipient in the spring of 2017.
Trio Labs’ 3D Printer Aims for Mass Production of Metal & Ceramic
